Cargando…
LncRNA CASC11 was downregulated in coronary artery disease and inhibits transforming growth factor-β1
OBJECTIVE: To investigate the involvement of long non-coding RNA (lncRNA) Cancer Susceptibility 11 (CASC11) in patients with coronary artery disease (CAD). METHODS: This case–control study enrolled patients with CAD and age- and sex-matched healthy control subjects. The plasma levels of lncRNA CASC1...
Autores principales: | Chen, Junhua, Dang, Jianli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133399/ https://www.ncbi.nlm.nih.gov/pubmed/32223575 http://dx.doi.org/10.1177/0300060519889187 |
Ejemplares similares
-
The lncRNA CASC9 alleviates lipopolysaccharide-induced acute kidney
injury by regulating the miR-424-5p/TXNIP pathway
por: Fan, Hai-Peng, et al.
Publicado: (2021) -
lncRNA CASC2 downregulation participates in rheumatoid arthritis, and CASC2 overexpression promotes the apoptosis of fibroblast-like synoviocytes by downregulating IL-17
por: Liu, Cheng, et al.
Publicado: (2020) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
LncRNA-NEF is downregulated in postmenopausal osteoporosis and is related to course of treatment and recurrence
por: Ma, Xiaoyong, et al.
Publicado: (2019) -
LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11
por: Su, Xiaohui, et al.
Publicado: (2019)